Osteopontin--a molecule for all seasons (Q34522057)

2 August 2017

1 reference

title

Osteopontin--a molecule for all seasons (English)

1 reference

2 August 2017

Mazzali M

1 reference

2 August 2017

Kipari T

1 reference

2 August 2017

Ophascharoensuk V

1 reference

2 August 2017

Wesson JA

1 reference

2 August 2017

Johnson R

1 reference

2 August 2017

Hughes J

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

QJM: An International Journal of Medicine

2 August 2017

published in

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

3-13

1 reference

Osteopontin regulation in cultured rat renal epithelial cells

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Vitamin D receptor interactions with the murine osteopontin response element.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

TGFbeta and BMP-2 activation of the OPN promoter: roles of smad- and hox-binding elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

High expression of genes for calcification-regulating proteins in human atherosclerotic plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Reduced tolerance to acute renal ischemia in mice with a targeted disruption of the osteopontin gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Osteopontin function in pathology: lessons from osteopontin-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Expression of proteins that inhibit calcium oxalate crystallization in vitro in the urine of normal and stone-forming individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Glomerular osteopontin expression and macrophage infiltration in glomerulosclerosis of DOCA-salt rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Osteopontin expression correlates with clinical outcome in patients with mycobacterial infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Costimulation by extracellular matrix proteins determines the response to TCR ligation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

The role of Eta-1/osteopontin in the pathogenesis of immunological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Coupling of osteopontin and its cell surface receptor CD44 to the cell survival response elicited by interleukin-3 or granulocyte-macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Age and development-related changes in osteopontin and nitric oxide synthase mRNA levels in human kidney proximal tubule epithelial cells: contrasting responses to hypoxia and reoxygenation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Altered wound healing in mice lacking a functional osteopontin gene (spp1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Expression of osteopontin in gentamicin-induced acute tubular necrosis and its recovery process

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Estrogen attenuates integrin-beta(3)-dependent adventitial fibroblast migration after inhibition of osteopontin production in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

Targeted inhibition of osteopontin expression in the mammary gland causes abnormal morphogenesis and lactation deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F95.1.3

21 January 2018

Identifiers

DOI

10.1093/QJMED/95.1.3

1 reference

release_kegtdrlcgfcmdp462skuz7msey

2 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kegtdrlcgfcmdp462skuz7msey

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference